PlainRecalls
FDA Devices Critical Class I Ongoing

Philips BiPAP A30, Rx Only. To provide noninvasive ventilation support for patients with obstructive sleep apnea syndrome (OSA) and respiratory insufficiency.

Reported: September 14, 2022 Initiated: August 26, 2022 #Z-1654-2022

Product Description

Philips BiPAP A30, Rx Only. To provide noninvasive ventilation support for patients with obstructive sleep apnea syndrome (OSA) and respiratory insufficiency.

Reason for Recall

Motor assemblies manufactured with nonconforming plastic that contributes to off-gassing of VOCs.

Details

Recalling Firm
Philips Respironics, Inc.
Units Affected
146 units ***updated January 2024*** 30 additional units
Distribution
Domestic: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, ND, NH, NJ, NV, NY, OH, OK, OR, PA, TN, TX, VA, VT, WA, WI, WV, & WY. Foreign: Australia, Austria, Bangladesh, Brazil, Canada, China, Denmark, Egypt, France, Germany, Hong Kong, Hungary, India, Israel, Italy, Japan, Malaysia, Mexico, Myanmar, Philippines, Qatar, Serbia, Singapore, Taiwan, Thailand, Turkey, UAE, & UK.
Location
Murrysville, PA

Frequently Asked Questions

What product was recalled?
Philips BiPAP A30, Rx Only. To provide noninvasive ventilation support for patients with obstructive sleep apnea syndrome (OSA) and respiratory insufficiency.. Recalled by Philips Respironics, Inc.. Units affected: 146 units ***updated January 2024*** 30 additional units.
Why was this product recalled?
Motor assemblies manufactured with nonconforming plastic that contributes to off-gassing of VOCs.
Which agency issued this recall?
This recall was issued by the FDA Devices on September 14, 2022. Severity: Critical. Recall number: Z-1654-2022.